Selection procedure reference: EMA/TR/8652
Deadline for applications: 19 June 2022 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
The 2022 Traineeship programme is now open for applications until 19 June 2022 23:59 CET, with an intake on 1 October 2022.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students, who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee to support the Human Medicines Division, and its Meeting Secretariat Office.
Specific objectives and projects
During your traineeship, you will:
1) Implement a revised system for the management of external queries on herbal substances/medicines/legislation/monographs/borderline products (= ‘herbal queries’) with a view to reducing the number of incoming queries (AskEMA)
2) Extend existing glossary of terms on herbal medicines for publication on EMA website
3) Integrate content of Secretariat Office user manuals in HMPC Secretariat’s procedural documents
Learning outcomes
We will help you to:
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
In addition to the eligibility criteria, you will have:
Behavioural Competencies
You will demonstrate the following behavioural competencies: